The store will not work correctly when cookies are disabled.
N-[4-(1H-Indol-5-yloxy)-3,5-dimethyl-phenyl]-oxalamic acid ethyl ester
ID: ALA183829
PubChem CID: 44391409
Max Phase: Preclinical
Molecular Formula: C20H20N2O4
Molecular Weight: 352.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)C(=O)Nc1cc(C)c(Oc2ccc3[nH]ccc3c2)c(C)c1
Standard InChI: InChI=1S/C20H20N2O4/c1-4-25-20(24)19(23)22-15-9-12(2)18(13(3)10-15)26-16-5-6-17-14(11-16)7-8-21-17/h5-11,21H,4H2,1-3H3,(H,22,23)
Standard InChI Key: WFIFQXBGMJBOLB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.5167 -0.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3625 0.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8125 -0.6917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2375 -0.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3625 -0.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3500 0.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0750 -0.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2375 0.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0208 -0.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0875 0.9458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2375 -0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5000 0.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0667 0.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3500 -0.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8083 0.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5250 0.9333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0208 0.7833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5000 0.5583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 -1.4917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5250 -0.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8083 -0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9500 -0.2417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0833 -0.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3375 1.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6667 -0.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3750 -0.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 2 0
3 1 1 0
4 1 1 0
5 14 1 0
6 13 2 0
7 3 1 0
8 16 1 0
9 11 1 0
10 2 1 0
11 20 1 0
12 17 2 0
13 7 1 0
14 7 2 0
15 10 1 0
16 15 2 0
17 8 1 0
18 1 2 0
19 4 2 0
20 21 2 0
21 15 1 0
22 4 1 0
23 5 1 0
24 6 1 0
25 22 1 0
26 25 1 0
6 2 1 0
11 8 2 0
12 9 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.39 | Molecular Weight (Monoisotopic): 352.1423 | AlogP: 4.08 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.96 | CX Basic pKa: ┄ | CX LogP: 4.53 | CX LogD: 4.53 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -0.89 |
References
1. Haning H, Woltering M, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Pernerstorfer J.. (2005) Novel heterocyclic thyromimetics., 15 (7): [PMID:15780617] [10.1016/j.bmcl.2005.02.028] |